Chemed (CHE) Non-Current Deferred Tax Liability (2016 - 2025)
Historic Non-Current Deferred Tax Liability for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $9.7 million.
- Chemed's Non-Current Deferred Tax Liability fell 6549.72% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 6549.72%. This contributed to the annual value of $25.9 million for FY2024, which is 1443.22% down from last year.
- Latest data reveals that Chemed reported Non-Current Deferred Tax Liability of $9.7 million as of Q3 2025, which was down 6549.72% from $12.7 million recorded in Q2 2025.
- Chemed's 5-year Non-Current Deferred Tax Liability high stood at $38.6 million for Q4 2022, and its period low was $9.7 million during Q3 2025.
- Over the past 5 years, Chemed's median Non-Current Deferred Tax Liability value was $24.9 million (recorded in 2024), while the average stood at $24.8 million.
- In the last 5 years, Chemed's Non-Current Deferred Tax Liability soared by 8508.57% in 2023 and then plummeted by 6549.72% in 2025.
- Quarter analysis of 5 years shows Chemed's Non-Current Deferred Tax Liability stood at $23.2 million in 2021, then surged by 66.56% to $38.6 million in 2022, then dropped by 21.47% to $30.3 million in 2023, then dropped by 14.43% to $25.9 million in 2024, then plummeted by 62.66% to $9.7 million in 2025.
- Its Non-Current Deferred Tax Liability stands at $9.7 million for Q3 2025, versus $12.7 million for Q2 2025 and $11.8 million for Q1 2025.